Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) Return on Capital Employed (2021 - 2025)

Historic Return on Capital Employed for RxSight (RXST) over the last 5 years, with Q3 2025 value amounting to 0.16%.

  • RxSight's Return on Capital Employed fell 200.0% to 0.16% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.16%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.16% for FY2024, which is 1800.0% up from last year.
  • RxSight's Return on Capital Employed amounted to 0.16% in Q3 2025, which was down 200.0% from 0.15% recorded in Q2 2025.
  • RxSight's Return on Capital Employed's 5-year high stood at 0.13% during Q1 2025, with a 5-year trough of 0.47% in Q4 2022.
  • Its 5-year average for Return on Capital Employed is 0.28%, with a median of 0.31% in 2023.
  • Per our database at Business Quant, RxSight's Return on Capital Employed plummeted by -1800bps in 2022 and then surged by 1800bps in 2024.
  • Over the past 5 years, RxSight's Return on Capital Employed (Quarter) stood at 0.28% in 2021, then tumbled by -65bps to 0.47% in 2022, then skyrocketed by 33bps to 0.31% in 2023, then skyrocketed by 59bps to 0.13% in 2024, then fell by -24bps to 0.16% in 2025.
  • Its Return on Capital Employed was 0.16% in Q3 2025, compared to 0.15% in Q2 2025 and 0.13% in Q1 2025.